SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
152 hedge funds and large institutions have $1.72B invested in Sage Therapeutics in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
6% more funds holding
Funds holding: 144 → 152 (+8)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
152
Holding in Top 10
5
Calls
$24.9M
Puts
$21.8M
Top Buyers
| 1 | +$52.8M | |
| 2 | +$42.9M | |
| 3 | +$42.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$28.8M |
Top Sellers
| 1 | -$22M | |
| 2 | -$11.2M | |
| 3 | -$9.77M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$9.57M |
| 5 |
FHAM
Folger Hill Asset Management
New York
|
-$8.27M |